Literature DB >> 1407265

Regional distribution of tyrosine, tryptophan, and their metabolites in the brain of epileptic El mice.

S Suzuki1, A Mori.   

Abstract

Tyrosine, tryptophan, and their metabolites in the brain of ddY, non-stimulated El (El (-)), and stimulated El (El (+)) mice were measured using the three dimensional HPLC. The tryptophan content was lower in El (+) than ddY and El (-) mice. The 5-hydroxytryptophan content was much higher in both El groups. The serotonin content of El (+) was higher than that of ddY and El (-) mice. The kynurenine content was remarkably high in the El mice. The dopamine content was lower in El (-) than in ddY mice, whereas it was greater in El (+) than in El (-) mice. The norepinephrine showed higher levels in El (+) mice. These facts suggest that El mice possess congenital metabolic abnormalities of tryptophan and tyrosine and that kynurenine may play an important role as convulsant in El mice seizures along with changes in serotonin, dopamine, and norepinephrine that are inhibitory agents and responded to the repetitive convulsions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1407265     DOI: 10.1007/bf00968007

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  15 in total

1.  Metabolic defects in a convulsive strain of mouse.

Authors:  H NARUSE; M KATO; M KUROKAWA; T YABE
Journal:  J Neurochem       Date:  1960-06       Impact factor: 5.372

2.  Metabolic studies on ep mouse, a special strain with convulsive predisposition.

Authors:  M Kurokawa; H Naruse; M Kato
Journal:  Prog Brain Res       Date:  1966       Impact factor: 2.453

3.  gamma-Aminobutyric acid, benzodiazepine binding sites and gamma-aminobutyric acid concentrations in epileptic E1 mouse brain.

Authors:  H Hattori; M Ito; H Mikawa
Journal:  Eur J Pharmacol       Date:  1985-12-17       Impact factor: 4.432

4.  Brain catecholamine concentrations and convulsions in E1 mice.

Authors:  M Hiramatsu; A Mori
Journal:  Folia Psychiatr Neurol Jpn       Date:  1977

5.  Effect of convulsions of the synthesis of heterogeneous nuclear RNA associated with polyadenylate and oligoadenylate sequences from El mouse brain as a convulsive strain.

Authors:  H Onishi; S Yamagami; K Mori; Y Kawakita
Journal:  Exp Neurol       Date:  1984-01       Impact factor: 5.330

6.  Developmental alteration in RNA metabolism of E1 mouse brain.

Authors:  S Yamagami; K Ohno; M Tsuji; K Mori; Y Kawakita
Journal:  Folia Psychiatr Neurol Jpn       Date:  1981

7.  Distribution of Calbindin-D28K 1 (CaBP) in the cerebral cortex and hippocampus of the epileptic (El) mouse.

Authors:  I Mody; K G Baimbridge; J J Miller
Journal:  Epilepsy Res       Date:  1987-01       Impact factor: 3.045

8.  Reduced uptake and release of 5-hydroxytryptamine and taurine in the cerebral cortex of epileptic El mice.

Authors:  M Hiramatsu; K Ogawa; H Kabuto; A Mori
Journal:  Epilepsy Res       Date:  1987-01       Impact factor: 3.045

9.  Kynurenines and seizures.

Authors:  I P Lapin
Journal:  Epilepsia       Date:  1981-06       Impact factor: 5.864

10.  Alteration of RNA synthesis in vitro in intact cerebral cortex nuclei induced by convulsions in seizure-susceptible El mice.

Authors:  S Yamagami; H Onishi; K Ohno; K Mori; Y Kawakita
Journal:  Exp Neurol       Date:  1987-01       Impact factor: 5.330

View more
  3 in total

1.  Akitane Mori, the artistic neurochemist.

Authors:  Jiankang Liu; Midori Hiramatsu
Journal:  Neurochem Res       Date:  2008-10-21       Impact factor: 3.996

2.  New seizure frequency QTL and the complex genetics of epilepsy in EL mice.

Authors:  W N Frankel; A Valenzuela; C M Lutz; E W Johnson; W F Dietrich; J M Coffin
Journal:  Mamm Genome       Date:  1995-12       Impact factor: 2.957

3.  The anticonvulsant effect of citalopram on El mice, and the levels of tryptophan and tyrosine and their metabolites in the brain.

Authors:  H Kabuto; I Yokoi; M Takei; T Kurimoto; A Mori
Journal:  Neurochem Res       Date:  1994-04       Impact factor: 3.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.